A roundup of the 10 most recent FDA-approved medications.
New Drug Review
Betrixaban has been approved by the FDA for patients at risk for thromboembolisms.
What pharmacists need to know about the new antibody approved for multi-drug-resistant HIV-1.
FDA approves apalutamide for castration-resistant prostate cancer.
Netarsudil opthalmis solution (Rhopressa, Aerie Pharmaceuticals), is approved by the FDA for treatment of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Vabomere combines a carbapenem and a beta-lactamase inhibitor as a treatment for complicated urinary tract infections.
Emicizumab-kxwh brings together factors IXa and X to restore the function of the missing activated factor VIII and the blood clotting process.
A new era of treatment has arrived—here’s what you need to know.
The FDA approved Kevzara for RA patients.
Plecanatide: Approved for Chronic Idiopathic Constipation